These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 9568177

  • 1. Protein expression of p53, p21WAF1, and Rb as prognostic indicators in patients with surgically treated hepatocellular carcinoma.
    Naka T, Toyota N, Kaneko T, Kaibara N.
    Anticancer Res; 1998; 18(1B):555-64. PubMed ID: 9568177
    [Abstract] [Full Text] [Related]

  • 2. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
    Ito Y, Matsuura N, Sakon M, Miyoshi E, Noda K, Takeda T, Umeshita K, Nagano H, Nakamori S, Dono K, Tsujimoto M, Nakahara M, Nakao K, Taniguchi N, Monden M.
    Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644
    [Abstract] [Full Text] [Related]

  • 3. Altered retinoblastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis.
    Dosaka-Akita H, Hu SX, Fujino M, Harada M, Kinoshita I, Xu HJ, Kuzumaki N, Kawakami Y, Benedict WF.
    Cancer; 1997 Apr 01; 79(7):1329-37. PubMed ID: 9083154
    [Abstract] [Full Text] [Related]

  • 4. P21/WAF1 is an independent survival prognostic factor for patients with hepatocellular carcinoma after resection.
    Kao JT, Chuah SK, Huang CC, Chen CL, Wang CC, Hung CH, Chen CH, Wang JH, Lu SN, Lee CM, Changchien CS, Hu TH.
    Liver Int; 2007 Aug 01; 27(6):772-81. PubMed ID: 17617120
    [Abstract] [Full Text] [Related]

  • 5. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E.
    Int J Clin Pract; 2008 Nov 01; 62(11):1736-43. PubMed ID: 19143860
    [Abstract] [Full Text] [Related]

  • 6. Reduced p21(WAF1/CIP1) protein expression is predominantly related to altered p53 in hepatocellular carcinomas.
    Shi YZ, Hui AM, Takayama T, Li X, Cui X, Makuuchi M.
    Br J Cancer; 2000 Jul 01; 83(1):50-5. PubMed ID: 10883667
    [Abstract] [Full Text] [Related]

  • 7. The prevalence and clinicopathologic correlate of p16INK4a, retinoblastoma and p53 immunoreactivity in locally advanced urinary bladder cancer.
    Tzai TS, Tsai YS, Chow NH.
    Urol Oncol; 2004 Jul 01; 22(2):112-8. PubMed ID: 15082007
    [Abstract] [Full Text] [Related]

  • 8. Prognostic implications of molecular and immunohistochemical profiles of the Rb and p53 cell cycle regulatory pathways in primary non-small cell lung carcinoma.
    Burke L, Flieder DB, Guinee DG, Brambilla E, Freedman AN, Bennett WP, Jones RT, Borkowski A, Caporaso NA, Fleming M, Trastek V, Pairolero P, Tazelaar H, Midthun D, Jett JR, Liotta LA, Travis WD, Harris CC.
    Clin Cancer Res; 2005 Jan 01; 11(1):232-41. PubMed ID: 15671551
    [Abstract] [Full Text] [Related]

  • 9. Cyclin D1, p53, and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer.
    Bali A, O'Brien PM, Edwards LS, Sutherland RL, Hacker NF, Henshall SM.
    Clin Cancer Res; 2004 Aug 01; 10(15):5168-77. PubMed ID: 15297421
    [Abstract] [Full Text] [Related]

  • 10. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
    Tut VM, Braithwaite KL, Angus B, Neal DE, Lunec J, Mellon JK.
    Br J Cancer; 2001 Jan 01; 84(2):270-5. PubMed ID: 11161387
    [Abstract] [Full Text] [Related]

  • 11. Immunohistochemical study of cell cycle-associated proteins in adenocarcinoma of the uterine cervix treated with radiotherapy alone: P53 status has a strong impact on prognosis.
    Suzuki Y, Nakano T, Kato S, Ohno T, Tsujii H, Oka K.
    Int J Radiat Oncol Biol Phys; 2004 Sep 01; 60(1):231-6. PubMed ID: 15337561
    [Abstract] [Full Text] [Related]

  • 12. Expression of p27(KIP1) and p21(WAF1/CIP1) in primary hepatocellular carcinoma: clinicopathologic correlation and survival analysis.
    Qin LF, Ng IO.
    Hum Pathol; 2001 Aug 01; 32(8):778-84. PubMed ID: 11521219
    [Abstract] [Full Text] [Related]

  • 13. p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer.
    Shariat SF, Tokunaga H, Zhou J, Kim J, Ayala GE, Benedict WF, Lerner SP.
    J Clin Oncol; 2004 Mar 15; 22(6):1014-24. PubMed ID: 14981102
    [Abstract] [Full Text] [Related]

  • 14. Immunohistochemical expression of the p53, p21/Waf-1, Rb, p16 and Ki67 proteins in multiple myeloma.
    Kanavaros P, Stefanaki K, Vlachonikolis J, Papalazarou D, Rontogianni D, Arvanitis D, Antonakopoulos G, Gorgoulis V, Bai M, Agnantis NJ.
    Anticancer Res; 2000 Mar 15; 20(6B):4619-25. PubMed ID: 11205312
    [Abstract] [Full Text] [Related]

  • 15. p21WAF1/CIP1 expression is a marker of poor prognosis in oral squamous cell carcinoma.
    Nemes JA, Nemes Z, Márton IJ.
    J Oral Pathol Med; 2005 May 15; 34(5):274-9. PubMed ID: 15817070
    [Abstract] [Full Text] [Related]

  • 16. Disruption of p53-p21/WAF1 cell cycle pathway contributes to progression and worse clinical outcome of hepatocellular carcinoma.
    Lee TK, Man K, Poon RT, Lo CM, Ng IO, Fan ST.
    Oncol Rep; 2004 Jul 15; 12(1):25-31. PubMed ID: 15201954
    [Abstract] [Full Text] [Related]

  • 17. Tumor-suppressor effect of interferon regulatory factor-1 in human hepatocellular carcinoma.
    Moriyama Y, Nishiguchi S, Tamori A, Koh N, Yano Y, Kubo S, Hirohashi K, Otani S.
    Clin Cancer Res; 2001 May 15; 7(5):1293-8. PubMed ID: 11350897
    [Abstract] [Full Text] [Related]

  • 18. Correlations between p21 expression and clinicopathological findings, p53 gene and protein alterations, and survival in patients with endometrial carcinoma.
    Ito K, Sasano H, Matsunaga G, Sato S, Yajima A, Nasim S, Garret CT.
    J Pathol; 1997 Nov 15; 183(3):318-24. PubMed ID: 9422988
    [Abstract] [Full Text] [Related]

  • 19. [WAF1/CIP1 gene expression in human hepatocellular carcinoma and its relationship with p53 mutation].
    Zhu B, Cong W, Wang H.
    Zhonghua Gan Zang Bing Za Zhi; 1999 Dec 15; 7(4):217-20. PubMed ID: 10715791
    [Abstract] [Full Text] [Related]

  • 20. Prognostic factors in survival of patients with stage Ta and T1 bladder urothelial tumors: the role of G1-S modulators (p53, p21Waf1, p27Kip1, cyclin D1, and cyclin D3), proliferation index, and clinicopathologic parameters.
    Lopez-Beltran A, Luque RJ, Alvarez-Kindelan J, Quintero A, Merlo F, Requena MJ, Montironi R.
    Am J Clin Pathol; 2004 Sep 15; 122(3):444-52. PubMed ID: 15362377
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.